PhaseBio Pharmaceuticals, Inc. 16,000,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • March 19th, 2021 • PhaseBio Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 19th, 2021 Company Industry Jurisdiction